The isolation and identification of apolipoprotein C-I in hormone-refractory prostate cancer using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry

Asian Journal of Andrology

Volumn 11, Issue 3, 2009, Pages 299-307

  Yamamoto Ishikawa, Kaori ^a   Suzuki, Hiroyoshi ^a   Nezu, Masahiko ^a   Kamiya, Naoto ^a   Imamoto, Takashi ^a   Komiya, Akira ^a   Sogawa, Kazuyuki ^a   Tomonaga, Takeshi ^a   Nomura, Fumio ^a   Ichikawa, Tomohiko ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; APOLIPOPROTEIN C1; PROSTATE SPECIFIC ANTIGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; APOLIPOPROTEIN C I, HUMAN; APOLIPOPROTEIN C-I, HUMAN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; METASTASIS POTENTIAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN ISOLATION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; AMINO ACID SEQUENCE; BLOOD; CELL LINE; DISEASE COURSE; DRUG RESISTANCE; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PROGNOSIS; PROSTATE TUMOR; PROTEIN MICROARRAY; WESTERN BLOTTING;

AGED; AMINO ACID SEQUENCE; ANTINEOPLASTIC AGENTS, HORMONAL; APOLIPOPROTEIN C-I; BLOTTING, WESTERN; CELL LINE; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROGNOSIS; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 69249220291     PISSN: 1008682X     EISSN: 17457262     Source Type: Journal    
DOI: 10.1038/aja.2008.38     Document Type: Article

References (24)

1. Huggins C, Hodges CV. The effect of castration of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-7.
2. Schmidt JD. The patient, disease status, and treatment options for prostate cancer: Stages D1 and D2. Prostate 1983; 4: 493-501.
3. Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, et al. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 1999; 59: 2511-5.
4. Suzuki H, Ueda T, Ichikawa T, Ito H. Androgen receptor involvement in progression of prostate cancer. Endocr Relat Cancer 2003; 10: 209-16.
5. Nomura F, Tomonaga T, Sogawa K, Ohashi T, Nezu M, et al. Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization-mass spectrometry. Proteomics 2004; 4: 1187-94.
6. Liu AY, Zhang H, Sorensen CM, Diamond DL. Analysis of prostate cancer by proteomics using tissue specimens. J Urol 2005; 173: 73-8.
7. Kozak KR, Amneus MW, Pusey SM, Su F, Luong MN, et al. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 2003; 100: 12343-8.
8. Paradis V, Degoes F, Dagère D, Pham N, Belghiti J, et al. Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005; 41: 40-7.
9. Rosty C, Christa L, Kuzdazal S, Baldwin WM, Zahurak ML, et al. Identification of hepatocarcinoma-intestine-pancreas/ pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002; 62: 1868-75.
10. Li J, White N, Zhang Z, Rosenzweig J, Mangold LA, et al. Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. J Urol 2004; 171: 1782-7.
11. Gretzer MB, Partin AW. Prostate cancer tumor markers. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, et al. editors. Campbell-Walsh Urology, 9th edn. Philadelphia: Saunders; 2007. p2896-911.
12. Cho D, Di Blasio CJ, Rhee AC, Kattan MW. Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation. Urol Oncol 2003; 21: 282-91.
13. Nishio Y, Yamada Y, Kokubo H, Nakamura K, Aoki S, et al. Prognostic significance of immunohistochemical expression of the HER-2/ neu oncoprotein in bone metastatic prostate cancer. Urology 2006; 68: 110-5.
14. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999; 19: 472-84.
15. Gong Z, Agalliu L, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risk of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 2007; 109: 1192-202.
16. Kristal AR, Gong Z. Obesity and prostate cancer mortality. Future Oncol 2007; 3: 557-67.
17. Hughes-Fulford M, Chen Y, Tjandra Winata RR. Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells. Carcinogenesis 2001; 22: 701-7.
18. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, et al. Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 2006; 66: 2815-25.
19. Malik G, Ward MD, Gupta SK, Trosset MW, Grizzle WE, et al. Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 2005; 11: 1073-85.
20. Hall RE, Horsfall DJ, Stahl J, Vivekanandan S, Ricciardelli C, et al Apolipoprotein-D: A novel cellular marker for HG-PIN and prostate cancer. Prostate 2004; 58: 103-8.
21. Goncçalves A, Esterni B, Bertucci F, Sauvan R, Chabannon C, et al Postoperative serum proteomic profiles may predict meta-static relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 2006; 25: 981-9.
22. Engwegen JY, Helgi HH, Cats A, Harris N, Bonfrer JM, et al. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorpt ion ionisation-time of flight mass spectrometry. World J Gastroenterol 2006; 12: 1536-44.
23. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004; 95: 385-92.
24. Iacobuzio-Donahue CA, Ryu B, Hruban RH, Kern SE. Exploring the host desmoplastic response to pancreatic carcinoma. Am J Pathol 2002; 160: 91-9.